Indeed, several chemotherapeutic agents, such as doxorubicin, gemcitabine, cisplatin and etoposide, have been linked to TF upregulation, increased TF activity and/or secretion of TF-positive extracellular vesicles (EVs) in a variety of cancer types in vitro [16,17,18,19]. Here, TF is linked to cancer.